About David Kirske
David Kirske is a chief financial officer at X4 Pharmaceuticals.
Form D filings name David Kirske as an executive officer at Garuda Therapeutics.
David Kirske reports to the SEC as an officer of 2 public companies, including Cti Biopharma (CTIC).
David Kirske first appears on SEC filings in 2017.
Experience
This experience comes from SEC filings. The years are when the filings name David Kirske in the role, so the role may have started earlier or lasted longer.
XI
X4 Pharmaceuticals, Inc
Chief Financial Officer
2025 – 2026 · Public company (XFOR)
CC
Cti Biopharma Corp.
EVP, Chief Financial Officer
2017 – 2023 · Public company (CTIC)
Key Colleagues at Startups
The people David Kirske works with at each company, as listed on that company's latest Form D.
Garuda Therapeutics, Inc. · Form D, Oct 31, 2024
GM
Geoff Meyerson
Director
RK
Raymond Kelleher
Director
EA
Eric Aguiar
Director
SL
Steve Liapis
Director
RS
Rahul Singhvi
Director
CG
Carl Gordon
Director
AC
Adam Craig
President and CEO, director